Skip to main content
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
User login
Username
Password
Reset your password
Type
Lead
score